Newt Gingrich @newtgingrich
Small biotech firms are a critical (and overlooked) link in the drug development process. Heated rhetoric against big drug companies ignores impact price controls would have on the little guys and new cure development. https://t.co/eZmTvG07x8 — PolitiTweet.org